This week a study suggesting that very hot drinks can triple the risk of oesophageal cancer gained much […]
Category: Oncology
A new drug to treat resistant ovarian cancer, and the first to be approved in over two decades, […]
Screening with a PSA (prostate specific antigen) blood test reduces prostate cancer deaths by two for every 1000 […]
The company will initially develop a vaccine to tackle colorectal and pancreatic cancers
Ovarian cancer is the fifth leading cause of deaths from cancer in women
The vaccine could be created as a ready-to-use product, rather than needing to be personalised
MRM’s platform could optimise the link between the gut microbiome and cancer outcomes
The pilot will see GP practices look at patient records to identify those most at risk
The candidate is being evaluated as both a monotherapy and in combination pembrolizumab
The alliance combines Lumanity’s commercial and development strategy capabilities with PICI’s translational research expertise